Electroacupuncture for treating diabetic nerve pain
Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy and Its Correlation With Nerve Conduction Changes
This study is testing if electroacupuncture can help people with type 2 diabetes and nerve pain feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 40 Years to 75 Years |
| Sex | All |
| Sponsor | Instituto Mexicano del Seguro Social Government |
| Locations | 1 site (Mexico City, Cuauhtémoc) |
| Trial ID | NCT05521737 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of electroacupuncture on reducing neuropathic pain and improving quality of life in patients with type 2 diabetes mellitus who have diabetic peripheral polyneuropathy. Participants will undergo a series of assessments, including questionnaires and nerve conduction studies, to determine their eligibility. Those who qualify will be randomly assigned to receive either electroacupuncture or sham acupuncture over 32 sessions. The study will also evaluate changes in biochemical markers, inflammatory responses, and genetic expression related to the condition.
Who should consider this trial
Good fit: Ideal candidates are adults with type 2 diabetes and a clinical diagnosis of diabetic peripheral polyneuropathy.
Not a fit: Patients with type 1 diabetes, gestational diabetes, or other significant neurological disorders are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly alleviate neuropathic pain and enhance the quality of life for patients with diabetic peripheral neuropathy.
How similar studies have performed: Previous studies have shown promising results for acupuncture and electroacupuncture in managing neuropathic pain, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with type 2 diabetes. * Patients with clinical diabetic peripheral polyneuropathy. * Patients with electrophysiological diagnosis of diabetic peripheral polyneuropathy in its different types of classification. Exclusion Criteria: * Type 1 Diabetes or gestational diabetes. * Systemic autoimmune diseases. * Hematological disorders. * HIV diagnosis. * Cancer in treatment. * Pregnancy. * Other types of neurological disorders or neuropathies. * Intervention with acupuncture six months previously. * Patients with pacemarkers.
Where this trial is running
Mexico City, Cuauhtémoc
- Medical research unit in biochemistry, UMAE "Dr. Bernardo Sepúlveda".Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social. — Mexico City, Cuauhtémoc, Mexico (Recruiting)
Study contacts
- Principal investigator: José de Jesús Peralta Romero, PhD — Instituto Mexicano del Seguro Social
- Study coordinator: José de Jesús Peralta Romero, PhD
- Email: drjjperalta@gmail.com
- Phone: 5532318563
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.